We analyzed separately all MG (n=24), untreated MG (n=18) and treated MG (n=6) patients versus controls for cell populations that were different between controls and all MG patients with a p-value below 0.1 (Table 1): Monocyte subpopulations (Figures 4A–D), ILC2 (Figure 4E), CD27- but also CD27+ γδ T cells (Figures 4F, G), Treg cells (Figure 4H), Breg cells (Figure 4I) and CD161+CD8+ T cells (Figure 4J). This evidence concerns the gene CD8A and myasthenia gravis.